Objective:
To discuss the impact of AI on the pharmaceutical workforce and investment trends.
Approach:
- AI's Impact on the Pharma Workforce: A session exploring how AI is expected to change job roles in the pharmaceutical sector, with 90,000 traditional roles anticipated to disappear while new jobs requiring different skills will emerge.
- Emerging Pharma Trends and CDMO Innovation: A session focused on current challenges in the pharmaceutical supply chain and the importance of collaboration and resilience.
- Pharma Investment Map: A session examining how trade friction and new policies are altering capital flows in pharmaceutical manufacturing.
Key Findings:
- 90,000 traditional roles in pharma are expected to vanish due to AI.
- New jobs will emerge that require different skills.
- Trade and policy changes are reshaping capital flows in pharma manufacturing.
Interpretation:
Limitations:
- The article does not provide specific data or case studies to support the claims.
- No direct quotes from experts or session speakers are included.
Conclusion:
The conference sessions aim to address the future of the pharmaceutical workforce and investment strategies in light of emerging trends.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
